Prevention of disease flares by risk-adapted stratification of therapy withdrawal in juvenile idiopathic arthritis: results from the PREVENT-JIA trial

“Every little furrow of her brow makes me want to stop”: An Interpretative Phenomenological Analysis of Mothers’ Experiences with Juvenile Idiopathic Arthritis Treatments

(2021) Yvonne N. Brandelli et al.   ARTHRITIS CARE & RESEARCH

Update on the treatment of nonsystemic juvenile idiopathic arthritis including treatment-to-target: is (drug-free) inactive disease already possible?

(2020) Inge R. Klein-Wieringa et al.   CURRENT OPINION IN RHEUMATOLOGY

Treatment Withdrawal Following Remission in Juvenile Idiopathic Arthritis: A Systematic Review of the Literature

(2019) Olha Halyabar et al.   PEDIATRIC DRUGS

Making Decisions About Stopping Medicines for Well‐Controlled Juvenile Idiopathic Arthritis: A Mixed‐Methods Study of Patients and Caregivers

(2019) Daniel B. Horton et al.   ARTHRITIS CARE & RESEARCH

Treating juvenile idiopathic arthritis to target: recommendations of an international task force

(2018) Angelo Ravelli et al.   ANNALS OF THE RHEUMATIC DISEASES

Calcium and zinc tune autoinflammatory toll-like receptor 4 signaling by S100A12

(2018) Christoph Kessel et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Flares After Withdrawal of Biologic Therapies in Juvenile Idiopathic Arthritis: Clinical and Laboratory Correlates of Remission Duration

(2018) Gabriele Simonini et al.   ARTHRITIS CARE & RESEARCH

Serum S100A8/A9 and S100A12 Levels in Children with Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinical Inactive Disease During and Flare after Discontinuation of Anti-TNF Therapy

(2018) Claas H. Hinze et al.   Arthritis & Rheumatology

S100A12 Serum Levels and PMN Counts Are Elevated in Childhood Systemic Vasculitides Especially Involving Proteinase 3 Specific Anti-neutrophil Cytoplasmic Antibodies

(2018) Kelly L. Brown et al.   Frontiers in Pediatrics

Attitudes and Approaches for Withdrawing Drugs for Children with Clinically Inactive Nonsystemic JIA: A Survey of the Childhood Arthritis and Rheumatology Research Alliance

(2017) Daniel B. Horton et al.   JOURNAL OF RHEUMATOLOGY

The risk and nature of flares in juvenile idiopathic arthritis: results from the ReACCh-Out cohort

(2015) Jaime Guzman et al.   ANNALS OF THE RHEUMATIC DISEASES

Management of juvenile idiopathic arthritis: hitting the target

(2015) Claas Hinze et al.   Nature Reviews Rheumatology

Impact of Medication Withdrawal Method on Flare-Free Survival in Patients with Juvenile Idiopathic Arthritis on Combination Therapy

(2015) Caroline Y. Chang et al.   ARTHRITIS CARE & RESEARCH

Proinflammatory S100A12 Can Activate Human Monocytes via Toll-like Receptor 4

(2013) Dirk Foell et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

An immunological biomarker to predict MTX response in early RA

(2013) Frederique Ponchel et al.   ANNALS OF THE RHEUMATIC DISEASES

Validation of Relapse Risk Biomarkers for Routine Use in Patients With Juvenile Idiopathic Arthritis

(2013) Friederike Rothmund et al.   ARTHRITIS CARE & RESEARCH

Phagocyte-specific S100 proteins and high-sensitivity C reactive protein as biomarkers for a risk-adapted treatment to maintain remission in juvenile idiopathic arthritis: a comparative study

(2012) Joachim Gerss et al.   ANNALS OF THE RHEUMATIC DISEASES

Methotrexate Withdrawal at 6 vs 12 Months in Juvenile Idiopathic Arthritis in RemissionA Randomized Clinical Trial

(2010) Dirk Foell   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The meaning of clinical remission in polyarticular juvenile idiopathic arthritis: Gene expression profiling in peripheral blood mononuclear cells identifies distinct disease states

(2009) Nicholas Knowlton et al.   ARTHRITIS AND RHEUMATISM

Abnormal T cell differentiation persists in patients with rheumatoid arthritis in clinical remission and predicts relapse

(2007) C H Burgoyne et al.   ANNALS OF THE RHEUMATIC DISEASES